Atlas Trials

Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy

Clinical trial NCT06602843 · RECRUITING

Trial details

NCT number
NCT06602843
Sponsor
Anhui Provincial Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2024-01-01
Primary completion
2026-12-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.